| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner, See Remarks Below | Director, 10% Owner
1 company
Peyer James is a 10% Owner, See Remarks Below at SNSE. Recent filings cover 61 purchases and 10 sales. Those positions are worth an estimated $2.8M at current prices.
Our model assigns Peyer James a below-average insider score of 27/100, based on 51 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -70.9%.
Peyer James's largest disclosed position is in SNSE as 10% Owner, See Remarks Below, worth about $2.8M. Net of sales, the recent Form 4 record there shows accumulation of 488,929 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2021 | SNSE Sensei Biotherapeutics, Inc. | Director, 10% Owner | Buy | 3,000 | $16.25 | $48,750.00 | - | |
| Feb 26, 2021 | SNSE Sensei Biotherapeutics, Inc. | Director, 10% Owner | Buy | 5,000 | $16.25 | $81,250.00 | +0.1% | |
| Feb 25, 2021 | SNSE Sensei Biotherapeutics, Inc. | Director, 10% Owner | Buy | 31,000 | $16.48 | $510,862.00 | +0.2% | |
| Feb 23, 2021 | SNSE Sensei Biotherapeutics, Inc. | Director, 10% Owner | Buy | 20,300 | $17.79 | $361,070.00 | +0.2% | |
| Feb 22, 2021 | SNSE Sensei Biotherapeutics, Inc. | Director, 10% Owner | Buy | 9,802 | $18.88 | $185,061.76 | +0.2% | |
| Feb 19, 2021 | SNSE Sensei Biotherapeutics, Inc. | Director, 10% Owner | Buy | 11,786 | $19.77 | $233,009.22 | +0.3% | |
| Feb 18, 2021 | SNSE Sensei Biotherapeutics, Inc. | Director, 10% Owner | Buy | 753 | $19.75 | $14,871.75 | - |